Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study
-
- Thomas S. Uldrick
- Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
-
- Priscila H. Gonçalves
- HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
-
- Maher Abdul-Hay
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
-
- Alisa J. Claeys
- Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
-
- Brinda Emu
- Yale University, New Haven, Connecticut
-
- Marc S. Ernstoff
- Roswell Park Cancer Institute, Buffalo, New York
-
- Steven P. Fling
- Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
-
- Lawrence Fong
- University of California San Francisco, San Francisco
-
- Judith C. Kaiser
- Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
-
- Andreanne M. Lacroix
- Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
-
- Steve Y. Lee
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
-
- Lisa M. Lundgren
- Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
-
- Kathryn Lurain
- HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
-
- Christopher H. Parsons
- Louisiana State University Health Science Center, New Orleans
-
- Sharavi Peeramsetti
- Axio Research, Seattle, Washington
-
- Ramya Ramaswami
- HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
-
- Elad Sharon
- HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
-
- Mario Sznol
- Yale University, New Haven, Connecticut
-
- Chia-Ching (Jackie) Wang
- Zuckerberg San Francisco General Hospital, San Francisco, California
-
- Robert Yarchoan
- HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
-
- Martin A. Cheever
- Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
収録刊行物
-
- JAMA Oncology
-
JAMA Oncology 5 (9), 1332-, 2019-09-01
American Medical Association (AMA)